Basics Third Harmonic Bio, Inc. IPO Date: September 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $245.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 2.71% Avg Daily Range (30 D): $0.02 | 0.41% Avg Daily Range (90 D): $0.03 | 0.85% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 98 Avg Trade Size (Sh.) (90 D): 129 Institutional Trades Total Inst.Trades: 111 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $1.44M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.36M Avg Closing Trade (30 D): $1.85M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 328.83K     News Apr 14, 2025 @ 10:45 AM Third Harmonic Bio Announces Plan of Liquidation a... Source: N/A Feb 12, 2025 @ 9:41 PM Third Harmonic Bio Initiates Strategic Review, Lay... Source: Vandana Singh Nov 7, 2024 @ 9:00 PM Third Harmonic Bio to Participate in Upcoming Inve... Source: N/A May 28, 2024 @ 8:05 PM Third Harmonic Bio to Participate in the Jefferies... Source: Third Harmonic Bio May 15, 2024 @ 4:12 PM Biogen (BIIB) Partner Begins Filing for Leqembi SC... Source: Zacks Equity Research Financials   TTM Q1 2025 TTM Basic EPS $1.23 $.35 $.1 Diluted EPS $1.23 $.35 $.1 Revenue $ 12.86M $ 2.89M $ 87.66M Gross Profit $ $ $ 60.68M Net Income / Loss $ -53.45M $ -15.83M $ 2.9M Operating Income / Loss $ -66.3M $ -18.72M $ 2.38M Cost of Revenue $ $ $ 26.98M Net Cash Flow $ 15.99M $ M $ -14.97M PE Ratio 4.41